Find Federal Grants
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-215
Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-223
Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-057
Healthy Lifestyles in Youth
Indian Health Service · HHS-2022-IHS-HLY-0001
NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-031
NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-029
NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-028
NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-026
NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-23-025
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-024
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-023
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-013
REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AT-23-004
Agency for Health Care Research and Quality · PA-22-232
TB Free Uzbekistan
Kazakhstan USAID-Almaty · 72012222RFA00001
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-058
Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-054
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-032
HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain(R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-22-070
Connecting Machine Readable Digital Human AD/ADRD Neuropathological Library Platforms for Advanced Analytics (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-22-062